Abstract:Background Changes in IgG glycosylation, as a novel pathological feature, are observed in various autoimmune diseases (AIDs). The glycosylation patterns of IgG play a critical role in regulating the biological function and stability of IgG involved in the pathophysiology of many AIDs. However, the intracellular regulatory mechanisms underlying the effects of disturbances in various cytokines on IgG glycosylation are poorly understood. Thus, we investigated the regulatory effects of elevated cytokines in AIDs on intracellular IgG glycosylation within B cells. Methods First, we established a controlled primary culture system in vitro to differentiate human CD19 + B cells into antibody-secreting cells (ASCs). Then, the IgG concentrations in the supernatants were measured by enzyme-linked immunoassay (ELISA) under IFN-γ, TNF-α, IL-21, IL-17A, BAFF, or APRIL stimulation. Next, the glycosylation levels of IgG under different stimuli were compared via a lectin microarray. The fine carbohydrate structures of IgG were confirmed by matrix-assisted laser desorption/ionization-quadrupole ion trap-time of flight-mass spectrometry (MALDI-TOF-MS). Finally, the expression of glycosyltransferases and glycosidases in B cells under stimulation with several cytokines was detected by real-time PCR and western blotting. Results We found that cytokines significantly promoted IgG production in vitro and led to considerably different IgG glycan patterns. Specifically, the results of lectin microarray showed the galactose level of IgG was increased by IFN-γ stimulation ( p <0.05), and the sialylation of IgG was increased by IL-21 and IL-17A ( p <0.05). The MALDI-TOF-MS data showed that the frequency of agalactosylation was decreased by IFN-γ with the increased frequency of mono-galactosylation and decreased frequency of digalactosylation, accompanied by upregulation of β-1,4-galactosyltransferase 1. Both frequencies of mono-sialylated and disialylated N-glycans were increased by IL-21 and IL-17A with decreased frequency of asialylation, and the expression of β-galactoside α-2,6-sialyltransferase 1 was upregulated by IL-21 and IL-17A. Conclusion Abnormally elevated cytokines in the microenvironment regulates IgG glycan patterns by regulating intracellular glycosyltransferases in human B cells.

IgA subclasses have different effector functions associated with distinct glycosylation profiles

Effects of N-glycans on the structure of human IgA2

The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals

The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities

A whole blood-based functional assay to characterize immunoglobulin A effector functions

Immunoglobulin Glycosylation Effects in Allergy and Immunity

IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism

Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases

Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases

Influence of glycan modification on IgG1 biochemical and biophysical properties

Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases

Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases

Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases

IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity

Immunoglobulin A Glycosylation Differs between Crohn's Disease and Ulcerative Colitis

A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma

Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding

The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease

The Glycans Deficiencies Of Macromolecular Iga1 Is A Contributory Factor Of Variable Pathological Phenotypes Of Iga Nephropathy